Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2004
09/01/2004CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/01/2004CN1524852A Novel compounds with analgesic effect
09/01/2004CN1164582C Process for preparing danshen salviandic acid
09/01/2004CN1164581C Method for synthesizing 2-bromo-5-(2-bromo-2-nitrovinyl)-furan
08/2004
08/31/2004US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts
08/31/2004US6784302 Method of producing optically active lactone compound and complex used in the method
08/31/2004US6784299 Substituted aromatic ethers as inhibitors of glycine transport
08/31/2004US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP
08/31/2004US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/31/2004US6784173 Aromatic dicarboxylic acid derivatives
08/26/2004WO2004072057A1 3-phenylfuran-2-one derivatives as cox-2 inhibitor
08/26/2004WO2004072053A1 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
08/26/2004WO2004072031A2 Phenylacetamides and their use as glucokinase modulators
08/26/2004WO2004071442A2 Novel bicyclic compounds and compositions
08/26/2004WO2004058679A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
08/26/2004WO2004058164A3 Asthma and allergic inflammation modulators
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004WO2004013094A3 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/26/2004WO2004010936A3 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
08/26/2004US20040167357 Compounds and methods for preparing methanesulfonamides
08/26/2004US20040167344 Process for producing organotitanium compound and process for addition reaction
08/26/2004US20040167332 Boronic ester and acid compounds, synthesis and uses
08/26/2004US20040167216 Carbidopa prodrugs and derivatives, and compositions and uses thereof
08/26/2004US20040167210 Crystalline base of citalopram
08/26/2004US20040167209 Antidepressants; anxiolytic agents
08/26/2004US20040167184 Treatment of lung cells with histone deacetylase inhibitors
08/26/2004US20040167177 Decyclization an 1,3,5 tiiazine compound with hydrogen halide in presence of a nitrile
08/26/2004US20040167171 Prevention, therapy of neurodegenerative disease; diffusion through brain, blood barrier; Alzheimer's, Parkinson's Huntington's diseases, Amyotrophic lateral sclerosis
08/26/2004US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders
08/26/2004US20040167130 conducting a catalytic transesterification by reacting a low-carbon alkyl ester of mycophenolic acid with 2-morpholinoethanol to obtain a crude product of mycophenolate mofetil, which is then isolated and purified
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167116 Viricides
08/26/2004US20040167077 Prevent skin damage; therapy for skin disorders
08/26/2004US20040167031 Arylphenyl-substituted cyclic ketoenols
08/26/2004US20040167029 benzoylcyclohexanediones and benzoylpyrazoles for selectively controlling broad-leaved weeds and weed grasses in crops, in particular rice.
08/26/2004DE10306503A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
08/26/2004DE10164725B4 Verfahren zur Herstellung von gereinigtem Citalopram A method for preparing purified citalopram
08/26/2004DE10014670B4 Verfahren zur Extraktion und Isolierung von Santonin aus Artemisia sp. Methods for extraction and isolation of Santonin from Artemisia sp.
08/26/2004CA2515670A1 Phenylacetamides and their use as glucokinase modulators
08/26/2004CA2515638A1 Novel bicyclic compounds and compositions
08/25/2004EP1449840A1 Method of producing optically active lactone compound
08/25/2004EP1449838A1 Process for the preparation of 2-coumaranone and substituted 2-coumaranones
08/25/2004EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/25/2004EP1448567A1 Method for the preparation of hexahydro-furo 2,3-b]furan-3-ol
08/25/2004EP1448541A2 Preparation and use of gamma-butyrolactones as cross-linking agents
08/25/2004EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/25/2004EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade
08/25/2004EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
08/25/2004EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors
08/25/2004EP1448218A2 Beta-secretase inhibitors and methods of use
08/25/2004EP1448181A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
08/25/2004EP1448180A1 Para-amino benzoic acids as integrin antagonists
08/25/2004EP1347963B1 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
08/25/2004EP1244645B1 Stereospecific hydrolysis of optically active esters
08/25/2004EP1220822B1 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives
08/25/2004EP1149069B1 Phenylglycine derivatives
08/25/2004EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
08/25/2004EP0934302B1 Aminophenol derivates
08/25/2004EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/25/2004CN1524078A Antagonists of mcp-1 function and methods of use thereof
08/25/2004CN1524076A Method for the selective production of tetrahydrofuran by hydrogenating maleic acid anhydride
08/25/2004CN1524074A Method for producing 1,3-disubstituted 2-nitroguanidines
08/25/2004CN1524069A Addition of mineral acids or salts thereof to a TMA production process
08/25/2004CN1524006A Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures
08/25/2004CN1163493C Oxygen-containing heterocyclic compound
08/25/2004CN1163477C Substituted beta-alanine
08/25/2004CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof
08/24/2004US6781003 Preparation of pure citalopram
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/24/2004US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2
08/24/2004US6780887 Treating and/or preventing ischemia, pathologies associated with ischemia or pathologies associated with mitochondrial deficiencies
08/24/2004US6780862 Such as amino-indazoles for treatment of central nervous system disorders
08/24/2004US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
08/24/2004US6780858 Hydroxyamidines and related compounds
08/19/2004WO2004069831A1 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004069774A2 Synthesis of 13c-labelled estrogen analogues
08/19/2004WO2004069133A2 N-monoacylated o-phenylenediamines as anti -cancer agents
08/19/2004WO2004056763A3 Novel glucagon antagonists
08/19/2004WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
08/19/2004WO2003093258A3 Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162431 Permanent surface modifiers
08/19/2004US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease
08/19/2004US20040162340 Without the use of ozone or toxic reagents, intermediate for AIDS drug
08/19/2004US20040162339 such as 3-[3-(1-adamantyl)-4-methoxyphenyl]-3-methyl-2H-1-benzofuran-6-carboxylic acid for treatment of psoriasis, dermatitis, acne or seborrhoea; veterinary medicine
08/19/2004US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
08/19/2004US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/19/2004US20040162248 Preparation and diabetic use of gibberellins
08/19/2004US20040162217 Vanadium/phosphorus mixed oxide catalyst
08/19/2004US20040161404 Method for producing coupling compound
08/19/2004DE10306075A1 New 2,3-dialkyl-5-hydroxy-benzofuran derivatives, are antioxidants useful for treating e.g. inflammatory and autoimmune diseases, prepared by fermenting Malbranchea cinnamomea HKI 0286
08/19/2004CA2513401A1 N-monoacylated o-phenylenediamines as anti -cancer agents
08/18/2004EP1447400A1 Bicyclic compound
08/18/2004EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
08/18/2004EP1447396A1 Phthalic acid diamide derivatives, agriculture and horticultural insecticides, and a method for application of the insecticides
08/18/2004EP1446397A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
08/18/2004EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram